Welcome to our dedicated page for Insperity SEC filings (Ticker: NSP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Insperity, Inc. (NSP) SEC filings page on Stock Titan provides access to the company’s official regulatory disclosures, along with AI-powered summaries to help interpret complex documents. As a provider of human resources and business performance solutions, Insperity uses its filings to report on financial performance, capital structure, credit facilities, executive compensation and key commercial arrangements that affect its HR offerings.
Investors can review Insperity’s periodic reports, such as annual reports on Form 10-K and quarterly reports on Form 10-Q, to see detailed information on revenues, gross profit, operating expenses, net income, adjusted metrics and operating statistics like average worksite employees (WSEEs) paid per month. These filings also discuss risk factors, benefits cost trends, capital allocation, share repurchases and dividend activity, as referenced in the company’s earnings releases.
Current reports on Form 8-K are particularly important for tracking material events. Recent 8-K filings have described amendments to Insperity’s revolving credit facility, including increases in borrowing capacity, changes to leverage covenants and extensions of the maturity date, as well as an amendment to its arrangement with UnitedHealthcare that introduces additional expected cost savings, extended contract terms and options to limit claim costs per participant. Other 8-Ks cover quarterly financial results, updates to the HR solutions portfolio and special performance-based equity awards for senior executives tied to long-term stock price performance and the strategic partnership with Workday.
On this page, users can also access insider-related filings such as Form 4 to monitor transactions by Insperity executives and directors, and proxy materials that describe executive compensation programs and governance practices. Stock Titan’s AI tools summarize lengthy filings, highlight key terms in credit agreements and benefits arrangements, and explain how these disclosures relate to Insperity’s HR360, HRCore and HRScale solutions and its mission to help businesses succeed so communities prosper.
Reinhart Partners, LLC filed an amended Schedule 13G reporting its holdings in Insperity, Inc. common stock. The firm reports beneficial ownership of 2,745,035 shares, representing 7.28% of the outstanding class as of the event date.
Reinhart lists sole voting power over 2,507,622 shares and sole dispositive power over all 2,745,035 shares, with no shared voting or dispositive authority. The filer certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Insperity.
Mawer Investment Management Ltd. filed an amended Schedule 13G reporting beneficial ownership of 1,200,192 shares of Insperity, Inc. common stock, representing 3.18% of the outstanding class. Mawer has sole voting power over 1,194,663 shares and sole dispositive power over all 1,200,192 shares.
The filing notes that Mawer now holds 5 percent or less of Insperity’s common stock. Mawer certifies the shares were acquired and are held in the ordinary course of business, without the purpose or effect of changing or influencing control of Insperity.
Insperity, Inc. files its annual report describing a nationwide provider of outsourced human resources and business performance solutions for small and medium-sized U.S. companies. The core PEO HR Solutions bundle payroll, benefits, compliance support, HR technology, and people‑management services under co‑employment Client Service Agreements.
Key offerings include the HR360 and HR360 Select Edition platforms, the new Workday-based HRScale solution targeting middle‑market clients, and a traditional HRCore payroll and HCM product. Insperity served an average of 312,377 worksite employees in the fourth quarter of 2025, from 73 offices in 44 markets, with notable concentration in Texas, California, and New York.
The report highlights reliance on major partners UnitedHealthcare and Chubb for health and workers’ compensation coverage, tight labor market and inflation pressures, regulatory complexity, and exposure to economic cycles, health care reform, COVID-era employee retention credit reviews, and financial institution stability as important business risks.
Insperity reported weaker fourth-quarter and full-year 2025 results and announced a workforce realignment. Q4 revenues rose 3% to $1.7 billion with average paid worksite employees up 1%, but gross profit fell 21% to $172 million, leading to a net loss of $33 million and adjusted EBITDA of $(13) million.
For 2025, revenues grew 4% to $6.8 billion, while gross profit dropped 14% to $900 million, producing a net loss of $7 million versus a prior-year profit and adjusted EBITDA of $131 million. Management cited elevated healthcare costs as a key headwind.
The Realignment Plan will eliminate about 4% of non-sales roles, with an estimated one-time charge of roughly $9 million in Q1 2026, excluded from non-GAAP metrics. Despite recent losses, 2026 guidance calls for adjusted EPS of $1.69–$2.72 and adjusted EBITDA of $170–$230 million, implying a substantial profitability rebound.
BlackRock, Inc. filed an amended Schedule 13G to report its beneficial ownership of Insperity, Inc. common stock as of 12/31/2025. BlackRock reports beneficial ownership of 5,181,289 shares, representing 13.7% of Insperity’s outstanding common stock.
BlackRock has sole voting power over 5,124,977 shares and sole dispositive power over 5,181,289 shares, with no shared voting or dispositive power. The filing notes that one related holder, iShares Core S&P Small-Cap ETF, has an interest in more than five percent of Insperity’s common stock. BlackRock certifies that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Insperity.
Insperity, Inc. amended its revolving credit facility, increasing the maximum amount it may borrow from $650 million to $750 million and extending the facility’s maturity to December 15, 2028. The amendment also raises the amount by which the facility may be expanded from $700 million to $800 million, giving the company additional committed lending capacity.
The lenders agreed to increase the Maximum Leverage Ratio financial covenant from 3.00 to 3.75 and to revise the definition of EBITDA used in that covenant. Zions Bancorporation, N.A. dba Amegy Bank continues to act as administrative agent under the amended and restated credit agreement.
Insperity (NSP) reported insider open‑market purchases by a director. The filing shows buys of 2,000 shares at $34.25 on 11/06/2025 and 1,000 shares at $33.88 on 11/07/2025. Following these transactions, the director beneficially owned 25,707 shares, held directly.
Reinhart Partners LLC filed a Schedule 13G reporting beneficial ownership of 2,202,326 shares (5.92%) of Insperity, Inc. (NSP) as of 09/30/2025.
The filer reports sole voting power over 1,996,289 shares and sole dispositive power over 2,202,326 shares, with no shared voting or dispositive power. Reinhart identifies as an investment adviser and certifies the holdings were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control.
Insperity (NSP) reported Q3 2025 results showing revenue growth but weaker profitability. Revenue was $1.623 billion, up 4%, while gross profit fell 15% to $195 million. The quarter posted an operating loss of $25 million and a net loss of $20 million, or $0.53 per diluted share. Adjusted EBITDA was $10 million, down 74%. Average paid worksite employees (WSEEs) rose 1%.
Year-to-date, revenue reached $5.144 billion (up 4%), but net income declined to $26 million from $100 million, and adjusted EBITDA fell 42% to $144 million. Results were pressured by higher benefits costs and increased workers’ compensation expense, partly offset by 3% higher pricing.
Liquidity remained solid but down from year-end: cash, cash equivalents and marketable securities were $440 million, with long-term debt of $369 million and working capital of $172 million. Operating cash flow was an outflow of $533 million, reflecting payroll tax timing and client credit distributions. The company paid $0.60 per share in each quarter of 2025 and repurchased 45,000 shares, with authorization remaining for 1,407,764 shares.
Insperity (NSP) updated its health benefits arrangement with UnitedHealthcare. On November 3, 2025, a subsidiary signed an amendment that adds expected cost savings starting in 2026 and extends the arrangement through 2028.
The amendment lets Insperity annually choose to limit its responsibility for each participant’s claim costs to $500,000, $750,000, or $1,000,000 per year, revises certain administrative costs payable by the company, and adds volume-based incentives, subject to certain conditions. Other previously disclosed material terms remain unchanged.
Insperity also furnished a press release announcing financial and operating results for the quarter ended September 30, 2025; the release is provided as an exhibit.